Mark L. Bagarazzi

2014

In 2014, Mark L. Bagarazzi earned a total compensation of $1.2M as Chief Medical Officer at Inovio Pharmaceuticals, a 135% increase compared to previous year.

Compensation breakdown

Bonus$137,901
Option Awards$659,875
Salary$353,168
Other$10,817
Total$1,161,761

Bagarazzi received $659.9K in option awards, accounting for 57% of the total pay in 2014.

Bagarazzi also received $137.9K in bonus, $353.2K in salary and $10.8K in other compensation.

Rankings

In 2014, Mark L. Bagarazzi's compensation ranked 6,925th out of 13,032 executives tracked by ExecPay. In other words, Bagarazzi earned more than 46.9% of executives.

ClassificationRankingPercentile
All
6,925
out of 13,032
47th
Division
Manufacturing
2,537
out of 4,966
49th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
316
out of 736
57th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
170
out of 446
62nd
Industry
Surgical and Medical Instruments and Apparatus
95
out of 275
66th
Source: SEC filing on March 29, 2017.

Bagarazzi's colleagues

We found three more compensation records of executives who worked with Mark L. Bagarazzi at Inovio Pharmaceuticals in 2014.

2014

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2014

Niranjan Sardesai

Inovio Pharmaceuticals

Chief Operating Officer

2014

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like